Joseph H. Krushinski

1.6k total citations
38 papers, 1.2k citations indexed

About

Joseph H. Krushinski is a scholar working on Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Joseph H. Krushinski has authored 38 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Organic Chemistry, 16 papers in Molecular Biology and 11 papers in Cellular and Molecular Neuroscience. Recurrent topics in Joseph H. Krushinski's work include Neurotransmitter Receptor Influence on Behavior (8 papers), Pharmacological Receptor Mechanisms and Effects (6 papers) and Synthesis and Biological Evaluation (5 papers). Joseph H. Krushinski is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (8 papers), Pharmacological Receptor Mechanisms and Effects (6 papers) and Synthesis and Biological Evaluation (5 papers). Joseph H. Krushinski collaborates with scholars based in United States, Sweden and United Kingdom. Joseph H. Krushinski's co-authors include David W. Robertson, David T. Wong, Leroy R. Reid, J. David Leander, R W Fuller, Frank P. Bymaster, Harve Wilson, John M. Schaus, Raymond F. Kauffman and Virginia L. Wyss and has published in prestigious journals such as The FASEB Journal, Journal of Medicinal Chemistry and Critical Care Medicine.

In The Last Decade

Joseph H. Krushinski

35 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph H. Krushinski United States 18 412 382 313 268 130 38 1.2k
Terrance H. Andree United States 23 454 1.1× 653 1.7× 606 1.9× 366 1.4× 194 1.5× 51 1.8k
Katarzyna Kulig Poland 19 312 0.8× 382 1.0× 324 1.0× 110 0.4× 90 0.7× 81 1.0k
Kathryn A. Lyons United States 24 416 1.0× 514 1.3× 409 1.3× 98 0.4× 75 0.6× 45 1.6k
Jacek Sapa Poland 22 492 1.2× 547 1.4× 334 1.1× 197 0.7× 66 0.5× 119 1.7k
Jack J. Chen United States 29 518 1.3× 399 1.0× 375 1.2× 161 0.6× 215 1.7× 63 2.0k
Charles Gluchowski United States 21 351 0.9× 598 1.6× 600 1.9× 113 0.4× 104 0.8× 47 1.4k
Christoph A. Seyfried Germany 19 335 0.8× 416 1.1× 468 1.5× 138 0.5× 69 0.5× 41 1.1k
Carla Caccia Italy 19 427 1.0× 399 1.0× 416 1.3× 387 1.4× 96 0.7× 49 1.6k
Sarah Grimwood United States 28 401 1.0× 1.1k 2.8× 1.0k 3.2× 194 0.7× 109 0.8× 52 2.0k
Amedeo Leonardi Italy 28 525 1.3× 960 2.5× 537 1.7× 238 0.9× 130 1.0× 95 2.1k

Countries citing papers authored by Joseph H. Krushinski

Since Specialization
Citations

This map shows the geographic impact of Joseph H. Krushinski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph H. Krushinski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph H. Krushinski more than expected).

Fields of papers citing papers by Joseph H. Krushinski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph H. Krushinski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph H. Krushinski. The network helps show where Joseph H. Krushinski may publish in the future.

Co-authorship network of co-authors of Joseph H. Krushinski

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph H. Krushinski. A scholar is included among the top collaborators of Joseph H. Krushinski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph H. Krushinski. Joseph H. Krushinski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alsherbini, Khalid, et al.. (2018). Safety and Efficiency of Intravenous Push Lacosamide Administration. Neurocritical Care. 29(3). 491–495. 27 indexed citations
2.
Alsherbini, Khalid, et al.. (2017). 756: SAFETY AND EFFICIENCY OF INTRAVENOUS PUSH LACOSAMIDE ADMINISTRATION. Critical Care Medicine. 46(1). 364–364.
3.
Zhang, Deyi, María‐Jesús Blanco, Bai‐Ping Ying, et al.. (2015). Discovery of selective N-[3-(1-methyl-piperidine-4-carbonyl)-phenyl]-benzamide-based 5-HT1F receptor agonists: Evolution from bicyclic to monocyclic cores. Bioorganic & Medicinal Chemistry Letters. 25(19). 4337–4341. 5 indexed citations
4.
Yasuno, Fumihiko, Amira K. Brown, Sami S. Zoghbi, et al.. (2007). The PET Radioligand [11C]MePPEP Binds Reversibly and with High Specific Signal to Cannabinoid CB1 Receptors in Nonhuman Primate Brain. Neuropsychopharmacology. 33(2). 259–269. 63 indexed citations
5.
Lucaites, Virginia L., Joseph H. Krushinski, John M. Schaus, James E. Audia, & David L. Nelson. (2005). [3H]LY334370, a novel radioligand for the 5-HT1F receptor. II. Autoradiographic localization in rat, guinea pig, monkey and human brain. Naunyn-Schmiedeberg s Archives of Pharmacology. 371(3). 178–184. 35 indexed citations
6.
Wainscott, David B., Joseph H. Krushinski, James E. Audia, et al.. (2005). [3H]LY334370, a novel radioligand for the 5-HT1F receptor. I. In vitro characterization of binding properties. Naunyn-Schmiedeberg s Archives of Pharmacology. 371(3). 169–177. 19 indexed citations
7.
Zhang, Deyi, Joseph H. Krushinski, Sidney Liang, et al.. (2004). Design, synthesis and evaluation of bicyclic benzamides as novel 5-HT1F receptor agonists. Bioorganic & Medicinal Chemistry Letters. 14(24). 6011–6016. 15 indexed citations
8.
Bymaster, Frank P., Jeremy Findlay, P. T. Gallagher, et al.. (2004). Duloxetine (Cymbalta), a Dual Inhibitor of Serotonin and Norepinephrine Reuptake.. ChemInform. 35(12). 5 indexed citations
9.
Kaefer, Martin, James E. Audia, Nicholas Bruchovsky, et al.. (1996). Characterization of type I 5α-reductase activity in DU145 human prostatic adenocarcinoma cells. The Journal of Steroid Biochemistry and Molecular Biology. 58(2). 195–205. 26 indexed citations
10.
Gehlert, Donald R., Susan K. Hemrick-Luecke, Douglas A. Schober, et al.. (1995). (R)-thionisoxetine, a potent and selective inhibitor of central and peripheral norepinephrine uptake. Life Sciences. 56(22). 1915–1920. 17 indexed citations
11.
Gehlert, Donald R., Douglas A. Schober, Susan K. Hemrick-Luecke, et al.. (1995). Novel halogenated analogs of tomoxetine that are potent and selective inhibitors of norepinephrine uptake in brain. Neurochemistry International. 26(1). 47–52. 32 indexed citations
12.
Wong, David T., et al.. (1993). LY248686, A New Inhibitor of Serotonin and Norepinephrine Uptake. Neuropsychopharmacology. 8(1). 23–33. 187 indexed citations
13.
Wong, David T., et al.. (1993). Norfluoxetine Enantiomers as Inhibitors of Serotonin Uptake in Rat Brain. Neuropsychopharmacology. 8(4). 337–344. 85 indexed citations
14.
Gehlert, Donald R., Dale E. Mais, Susan L. Gackenheimer, Joseph H. Krushinski, & David W. Robertson. (1990). Localization of ATP sensitive potassium channels in the rat brain using a novel radioligand, [125I]iodoglibenclamide. European Journal of Pharmacology. 186(2-3). 373–375. 23 indexed citations
15.
Robertson, David W., Joseph H. Krushinski, Barbara G. Utterback, & Raymond F. Kauffman. (1989). Synthesis of a tritium-labeled indolidan analog and its use as a radioligand for phosphodiesterase-inhibitor cardiotonic binding sites. Journal of Medicinal Chemistry. 32(7). 1476–1480. 15 indexed citations
16.
Robertson, David W., et al.. (1988). Imidazole-pyridine bioisosterism: comparison of the inotropic activities of pyridine- and imidazole-substituted 6-phenyldihydropyridazinone cardiotonics. Journal of Medicinal Chemistry. 31(2). 461–465. 11 indexed citations
17.
Robertson, David W. & Joseph H. Krushinski. (1988). SYNTHESIS OF 2-[4-METHOXY-2-[2-(METHYLSULFINYL)ETHOXY]PHENYL]-1H-IMIDAZO[4, 5-b]PYRIDINE, A POTENT NONGLYCOSIDE INHIBITOR OF Na+, K+-ATPASE. Organic Preparations and Procedures International. 20(3). 311–316. 1 indexed citations
18.
Robertson, David W., Joseph H. Krushinski, R W Fuller, & J. David Leander. (1988). The absolute configurations and pharmacological activities of the optical isomers of fluoxetine, a selective serotonin-uptake inhibitor. Journal of Medicinal Chemistry. 31(7). 1412–1417. 137 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Terrance H. Andree Breakdown of academic impact, for papers by Katarzyna Kulig Breakdown of academic impact, for papers by Kathryn A. Lyons Breakdown of academic impact, for papers by Jacek Sapa Breakdown of academic impact, for papers by Jack J. Chen Breakdown of academic impact, for papers by Charles Gluchowski Breakdown of academic impact, for papers by Christoph A. Seyfried Breakdown of academic impact, for papers by Carla Caccia Breakdown of academic impact, for papers by Sarah Grimwood Breakdown of academic impact, for papers by Amedeo Leonardi
Rankless by CCL
2026